Search Ontology:
ChEBI
enasidenib
- Term ID
- CHEBI:145374
- Synonyms
-
- 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol
- AG 221
- AG-221
- CC-90007
- enasidenib
- enasidenibum
- Idhifa
- Definition
- A 1,3,5-triazine which is substituted by (2-hydroxy-2-methylpropyl)nitrilo, 6-(trifluoromethyl)pyridin-2-yl and [2-(trifluoromethyl)pyridin-4-yl]nitrilo groups at positions 2,4 and 6, respectively. It is an isocitrate dehydrogenase-2 (IDH2) inhibitor which has been approved for the treatment of adults with relapsed or refractory acute myeloid leukaemia (AML).
- References
-
- CAS:1446502-11-9
- DrugBank:DB13874
- KEGG:D10901
- PDBeChem:69Q
- PMID:28193778
- PMID:28280273
- PMID:28461409
- PMID:28659444
- PMID:28818952
- PMID:28879540
- PMID:29320949
- PMID:29742078
- PMID:29770715
- PMID:29803908
- PMID:30013764
- PMID:30069631
- PMID:30360730
- PMID:30386625
- PMID:30663096
- PMID:30719396
- PMID:30858735
- PMID:30967620
- PMID:31118877
- PMID:31454277
- PMID:31564968
- PMID:31652462
- Wikipedia:Enasidenib
- Ontology
- ChEBI ( EBI )
- is a type of
- has_role
-
Phenotype
Phenotype resulting from enasidenib
Phenotype where environments contain enasidenib
Phenotype modified by environments containing enasidenib
Human Disease Model